Skip to content Skip to footer
The InterGroup Corporation (NASDAQ: INTG) is emerging as a compelling turnaround story in 2025, combining solid real estate assets with a strategic push to unlock shareholder value and capitalize on market dislocations. Recent Highlights and Stock Momentum In August, InterGroup’s (INTG) shares…
London-listed Anglo American (AAL.L) and Canada's Teck Resources (TECK-B.TO) have sealed a transformative, “merger of equals” deal that will reshape the mining landscape—creating a copper powerhouse with a combined market capitalization north of $53 billion, headquarters in Vancouver, and core operations spanning…
Eupraxia Pharmaceuticals (NASDAQ: EPRX) is defining a new frontier in the treatment of eosinophilic esophagitis (EoE) with its innovative candidate, EP-104GI. This investigational therapy, developed with Eupraxia’s proprietary DiffuSphere™ technology, delivers long-lasting and locally targeted steroid treatment directly into the esophageal wall—offering…
HCW Wainwright has reiterated its Buy rating on Serina Therapeutics (NYSE American: SER), emphasizing both the company’s clinical progress and robust valuation metrics as key drivers for investor optimism. Company Snapshot and Market Performance Serina Therapeutics (SER) currently trades at $5.04 per share with a market…
U.S. corporations have crossed an extraordinary threshold in 2025, shattering records by eclipsing $1 trillion in share buybacks before the close of August—faster than any year in history. This landmark moment underscores a potent undercurrent of confidence among America’s corporate titans, driven…